Back
Applied Therapeutics Vs. Cellectar Biosciences Industry Stock Comparison
Sell
27
APLT
Applied Therapeutics
Last Price:
$0.88
Seasonality Move:
5.46%
Sell
37
CLRB
Cellectar Biosciences
Last Price:
$0.24
Seasonality Move:
-2.17%
Sell
27
Applied Therapeutics (APLT)
is a Sell
Is Applied Therapeutics a Buy, Sell or Hold?
-
The current Applied Therapeutics [APLT] share price is $0.88. The Score for APLT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
APLT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
-
The current Cellectar Biosciences [CLRB] share price is $0.24. The Score for CLRB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLT Stock Price Chart
What is Applied Therapeutics's stock price today?
-
The Applied Therapeutics share price today is $0.88Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLT is experiencing slight selling pressure.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $0.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.
APLT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.82 | Sell |
Relative Strength Index (14 RSI): | 16.8 | Sell |
Chaikin Money Flow: | -6309791 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.31 - 7.97) | Sell |
Bollinger Bands (100): | (3.84 - 9.3) | Sell |
CLRB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.43 | Sell |
Relative Strength Index (14 RSI): | 6.1 | Sell |
Chaikin Money Flow: | -1047529 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.52 - 1.72) | Sell |
Bollinger Bands (100): | (1.33 - 2.35) | Sell |
APLT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.1 | Sell |
20-day SMA: | 2.93 | Sell |
50-day SMA: | 6.62 | Sell |
200-day SMA: | 5.83 | Sell |
8-day EMA: | 1.23 | Sell |
20-day EMA: | 2.81 | Sell |
50-day EMA: | 5.11 | Sell |
200-day EMA: | 5.55 | Sell |
CLRB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.26 | Sell |
20-day SMA: | 0.98 | Sell |
50-day SMA: | 1.6 | Sell |
200-day SMA: | 2.49 | Sell |
8-day EMA: | 0.41 | Sell |
20-day EMA: | 0.85 | Sell |
50-day EMA: | 1.39 | Sell |
200-day EMA: | 2.17 | Sell |
Applied Therapeutics Earnings Growth & APLT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.94 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.
Applied Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cellectar Biosciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |